FDA Inspection
Biograft Transplant Services IncBiograft Transplant Services Inc – FDA Inspection, Feb 26, 2026
Record Details
This FDA Inspection record concerns Biograft Transplant Services Inc, with an inspection on February 26, 2026, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · 78b62334-0d38-4eb1-b391-d109f942a6bb
Inspection Facts
- Inspection number
- 1307000
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Biograft Transplant Services Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 22, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 7, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Biograft Transplant Services Inc
- FDA Inspection 1149912 - 2021-08-27
- FDA Inspection 1043589 - 2018-02-22
- FDA Inspection 983242 - 2016-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.